Status:
COMPLETED
Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer
Lead Sponsor:
Odense University Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
Prostate cancer is currently the leading newly diagnosed cancer in the industrialized world. Treatment of prostate cancer is highly dependent on the stage of the disease. Current methods for staging a...
Detailed Description
1. Introduction. Cancer of the prostate (PCa) is currently the leading newly diagnosed cancer and the second most common cause of cancer deaths among men in the industrialized world . In Denmark alone...
Eligibility Criteria
Inclusion
- Newly diagnosed, histologically verified PCa and
- Written consent and
- PSA ≥ 20 ng/mL and/or
- Gleason score \> 6 and/or
- cT-stage ≥ cT2c
Exclusion
- Withdrawal of consent or
- Other active malign disease
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT02232685
Start Date
September 1 2014
End Date
July 1 2016
Last Update
October 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospiatal
Odense, Denmark, 5000